Please use this identifier to cite or link to this item: https://doi.org/10.1002/jbm.a.31402
Title: Potential use of cholecalciferol polyethylene glycol succinate as a novel pharmaceutical additive
Authors: Zhao, H.Z.
Tan, E.C.
Yung, L.Y.L. 
Keywords: CPGS
Drug delivery
Nanoparticles
PLGA
TPGS
Vitamin D
Issue Date: 15-Mar-2008
Source: Zhao, H.Z., Tan, E.C., Yung, L.Y.L. (2008-03-15). Potential use of cholecalciferol polyethylene glycol succinate as a novel pharmaceutical additive. Journal of Biomedical Materials Research - Part A 84 (4) : 954-964. ScholarBank@NUS Repository. https://doi.org/10.1002/jbm.a.31402
Abstract: D-α-tocopheryl polyethylene glycol succinate (TPGS) has been utilized in numerous drug delivery formulations in recent years. Because of its amphiphilic structure, it can be used as emulsifier and vehicle for lipid-based drug delivery formulations. It is also an effective P-glycoprotein (P-gp) inhibitor. However, TPGS represents only one of the surfactants in the class of "Vitamin-PEG" conjugated surfactants. To design a new adjuvant or additive, a conjugate made of vitamin D (cholecalciferol) and PEG-cholecalciferol polyethylene glycol succinate (CPGS) was synthesized via a two-step reaction. We hypothesized that CPGS may exhibit similar characteristics to TPGS, and thus the physicochemical properties as well as the anticancer properties of CPGS were studied. The results demonstrated that CPGS reduced the particle size and increased the encapsulation efficiency of the PLGA nanoparticles, indicating that CPGS may also have the emulsifier function similar to TPGS. The drug release profiles showed that the nanoparticles with CPGS additive had a lower initial burst and more sustained release pattern. In vitro testing with Caco-2 cells showed that CPGS could increase the cytotoxicity of DOX-loaded PLGA nanoparticles. Based on the rhodamine accumulation study, the increased cytotoxicity is possibly due to the P-gp inhibition by CPGS. From current results, the use of CPGS as an adjuvant is promising and may enhance the efficacy of the overall drug delivery system. © 2007 Wiley Periodicals, Inc.
Source Title: Journal of Biomedical Materials Research - Part A
URI: http://scholarbank.nus.edu.sg/handle/10635/64442
ISSN: 15493296
DOI: 10.1002/jbm.a.31402
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

13
checked on Dec 7, 2017

WEB OF SCIENCETM
Citations

10
checked on Nov 22, 2017

Page view(s)

21
checked on Dec 11, 2017

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.